Skip to main content
Diseases

Leigh Syndrome

leigh syndrome

Entity Type
Diseases
Relation Groups
1
Relation Preview
8

Basic Information

Grouped by core information, identifiers, and descriptions.

Quick relations do not expand inferred candidates by default. Load path-derived ingredients or herbs when needed.

Core Information

Disease Name
Leigh Syndrome
Standard Disease Name
leigh syndrome
MeSH Tree
No data
ICD-10
No data

Identifiers

DO ID
No data
MeSH ID
No data
OMIM ID
256000
UMLS ID
C0023264|C1850597|C1850600|C1838951|C2931891|C1850598|C1850599
HPO ID
No data

Description and Extensions

Description
NCI2016_02D:An inherited disorder affecting the nervous system, caused by genetic mutations in the mitochondrial DNA or deficiency of pyruvate dehydrogenase. Signs and symptoms appear in infancy and include loss of the motor abilities, poor sucking abilities, irritability, lack of muscle tone, and seizures.|MSH2017_2016_08_12:A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. (From Menkes, Textbook of Child Neurology, 5th ed, p850).
Related

Direct relations and traceable candidates grouped by relation type.

Related Targets

target disease8 Targets
02
BCS1L
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
05
DLD
dihydrolipoamide dehydrogenase
dihydrolipoamide dehydrogenase
06
ECHS1
enoyl-CoA hydratase, short chain 1
enoyl-CoA hydratase, short chain 1